PCM
STIM icon

Peregrine Capital Management’s Neuronetics STIM Stock Holding History

Peregrine Capital Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-175,085
Closed -$4.66M – 326
2018
Q2 		$4.66M Buy
+175,085
New +$4.76M 0.12% 241

Other funds holding STIM

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Peregrine Capital Management's STIM Position: Q3 2018 in Review

Peregrine Capital Management sold out of Neuronetics (STIM) in Q3 2018, closing a stake of 175,085 shares — an estimated $4.66M sold.

Peregrine Capital Management first reported a position in STIM in Q2 2018 and held it in 1 quarter. The position peaked at $4.66M in Q2 2018. 74 funds tracked by Wall St. Rank hold STIM as of Q3 2018.

  • Peregrine Capital Management reported no remaining Neuronetics position as of Q3 2018 after selling out during the quarter.
  • Peregrine Capital Management sold 175,085 Neuronetics shares in Q3 2018, an estimated $4.66M.
  • Peregrine Capital Management first reported a position in Neuronetics in Q2 2018 and held it in 1 quarter.
  • Peregrine Capital Management's Neuronetics position peaked at $4.66M in Q2 2018.
  • 74 funds tracked by Wall St. Rank held Neuronetics as of Q3 2018.

Based on Peregrine Capital Management's 13F filing for Q3 2018, filed 18 Oct 2018.